RemeGen funding history / development milestones

IPO上市,

2022.03.31,上交所

Note: collected from public online reports, for reference only.

People who follow RemeGen also follow

RemeGen Competitors (Similar Companies)

“Customer-oriented, Efficient operations, Empower employees”
“A modern pharmaceutical enterprise spanning three major fields: modern”
“To become a world-class chemical new materials company with global ope”
“生化原料药生产”
“High-tech enterprise specializing in the development of uncooled infra”
工程设计 压缩设备 油气工程 油田技术服务
医药 生物医药 生物制药 胰岛素
“Research and development of recombinant protein drugs and microecologi”
“Improve the quality of life of the people, enhance the level of social”
再生医学 医用材料 生物医用材料 医疗器械
制药/药业 神经系统疾病药物 抗肿瘤药 抗生素
“从事生物药物研究开发生产的CDMO公司”
制药/药业 医药 原料药 植物提取
“Caring for life, safeguarding health”
“A renowned enterprise in China's liver disease and anti-tumor fields”